ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Design of a phase 3 trial to evaluate the long-term efficacy and safety of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
Neuromuscular Disorders
◽
10.1016/j.nmd.2017.06.447
◽
2017
◽
Vol 27
◽
pp. S218
Author(s):
P. Riebling
◽
E. O'Mara
◽
X. Luo
◽
P. Trifillis
◽
T. Ong
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Nonsense Mutation
◽
Efficacy And Safety
◽
Phase 3
◽
Term Efficacy
Download Full-text
Related Documents
Cited By
References
Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.3.supp.25
◽
2019
◽
Vol 3
◽
pp. S25
Author(s):
Benjamin Ehst
◽
George Han
◽
Scott Guenthner
◽
Kimberly Eads
◽
Abby Jacobson
Keyword(s):
Disease Duration
◽
Efficacy And Safety
◽
Phase 3
◽
Two Phase
◽
Term Efficacy
Abstract not available.
Download Full-text
P.11.18 Design of a confirmatory phase 3, multicenter, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
Neuromuscular Disorders
◽
10.1016/j.nmd.2013.06.579
◽
2013
◽
Vol 23
(9-10)
◽
pp. 804
Author(s):
J. Barth
◽
A. Reha
◽
R. Spiegel
◽
G.L. Elfring
◽
M. Husain
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Nonsense Mutation
◽
Controlled Study
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
◽
Confirmatory Phase
Download Full-text
Faculty Opinions recommendation of Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.736775334.793582407
◽
2021
◽
Author(s):
Varsha Gandhi
◽
Prithviraj Bose
Keyword(s):
Efficacy And Safety
◽
First Line
◽
Phase 3
◽
Term Efficacy
Download Full-text
Long-term efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis sustained for three years: Results of a randomized controlled phase 3 study (UNCOVER-3)
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2018.05.732
◽
2018
◽
Vol 79
(3)
◽
pp. AB180
Keyword(s):
Plaque Psoriasis
◽
Efficacy And Safety
◽
Phase 3
◽
Severe Plaque Psoriasis
◽
Randomized Controlled
◽
Term Efficacy
Download Full-text
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
Allergy Asthma & Clinical Immunology
◽
10.1186/s13223-020-0409-3
◽
2020
◽
Vol 16
(1)
◽
Author(s):
Donald S. Levy
◽
Henriette Farkas
◽
Marc A. Riedl
◽
Florence Ida Hsu
◽
Joel P. Brooks
◽
...
Keyword(s):
Subgroup Analysis
◽
Hereditary Angioedema
◽
Efficacy And Safety
◽
C1 Inhibitor
◽
Open Label
◽
Phase 3
◽
Term Efficacy
◽
Open Label Extension
Download Full-text
Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials
Journal of Clinical Immunology
◽
10.1007/s10875-018-0560-5
◽
2018
◽
Vol 38
(8)
◽
pp. 864-875
◽
Cited By ~ 6
Author(s):
Stephen Jolles
◽
Mikhail A. Rojavin
◽
John-Philip Lawo
◽
Robert Nelson
◽
Richard L. Wasserman
◽
...
Keyword(s):
United States
◽
Primary Immunodeficiency
◽
The United States
◽
Efficacy And Safety
◽
Phase 3
◽
Term Efficacy
Download Full-text
Lung function in ataluren-treated, non-ambulatory patients with nonsense mutation Duchenne muscular dystrophy from a long-term extension trial versus untreated patients from a natural history study
Neuromuscular Disorders
◽
10.1016/s0960-8966(17)30233-x
◽
2017
◽
Vol 27
◽
pp. S6
Author(s):
X. Luo
◽
J. McIntosh
◽
P. Trifillis
◽
A. Gill
◽
T. Ong
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Lung Function
◽
Natural History
◽
Nonsense Mutation
◽
Natural History Study
◽
Ambulatory Patients
◽
Extension Trial
Download Full-text
Lung Function in Ataluren-Treated, Nonambulatory Patients with Nonsense Mutation Duchenne Muscular Dystrophy from a Long-Term Extension Trial
Neuropediatrics
◽
10.1055/s-0037-1602955
◽
2017
◽
Vol 48
(S 01)
◽
pp. S1-S45
◽
Cited By ~ 1
Author(s):
C. Werner
◽
H. Kroger
◽
X. Luo
◽
J. McIntosh
◽
P. Trifillis
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Lung Function
◽
Nonsense Mutation
◽
Extension Trial
Download Full-text
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies
Journal of Pediatric Urology
◽
10.1016/j.jpurol.2019.12.012
◽
2020
◽
Vol 16
(2)
◽
pp. 180.e1-180.e8
◽
Cited By ~ 1
Author(s):
Israel Franco
◽
Piet Hoebeke
◽
Małgorzata Baka-Ostrowska
◽
David Bolong
◽
Leon N. Davies
◽
...
Keyword(s):
Detrusor Overactivity
◽
Pediatric Patients
◽
Efficacy And Safety
◽
Neurogenic Detrusor Overactivity
◽
Open Label
◽
Phase 3
◽
Two Phase
◽
Term Efficacy
Download Full-text
Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study
The Lancet Rheumatology
◽
10.1016/s2665-9913(20)30036-9
◽
2020
◽
Vol 2
(4)
◽
pp. e227-e235
◽
Cited By ~ 2
Author(s):
Iain B McInnes
◽
Philip J Mease
◽
Alan J Kivitz
◽
Peter Nash
◽
Proton Rahman
◽
...
Keyword(s):
Psoriatic Arthritis
◽
Efficacy And Safety
◽
Phase 3
◽
Term Efficacy
◽
Study Results
◽
Future 2
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close